Steroid-free liver transplantation in children
- PMID: 14697809
- DOI: 10.1016/S0140-6736(03)15104-5
Steroid-free liver transplantation in children
Abstract
Although corticosteroids have been part of immunosuppressive regimens since the early days of transplantation, steroid avoidance could be beneficial. To test this hypothesis in paediatric liver transplantation, we compared liver-transplantation under steroid-free immunosuppression in 20 children, who received combined tacrolimus and basiliximab, with that under tacrolimus and steroids in 20 matched historical recipients as a historical control group. 12-month rejection-free survival was 75% in the tacrolimus-basiliximab group compared with 50% in the steroid group (p=0.05). Growth in the first year after transplantation was significantly better in the tacrolimus-basiliximab group than in the steroid group. Steroid avoidance was, therefore, not harmful to our patients, and combining tacrolimus with basiliximab as a steroid substitution seems a safe alternative to tacrolimus and steroid immunosuppression.
Comment in
-
Steroid-free organ transplantation.Lancet. 2004 Feb 28;363(9410):737; author reply 737-8. doi: 10.1016/S0140-6736(04)15682-1. Lancet. 2004. PMID: 15001341 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical